PSG1
Pregnancy-specific beta-1-glycoprotein 1
Also known as: CD66f, PBG1, PSBG1, PSG1_HUMAN, PSGGA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11464
- Gene
- PSG1
- Ensembl
- ENSG00000231924
- Chromosome
- 19
- Canonical length
- 419 aa
- Protein class
- CD markers, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in female reproductive system
OverviewNCBI Gene
The human placenta is a multihormonal endocrine organ that produces hormones, enzymes, and other molecules that support fetal survival and development. Pregnancy-specific beta-1-glycoprotein (PSBG, PSG) is a major product of the syncytiotrophoblast, reaching concentrations of 100 to 290 mg/l at term in the serum of pregnant women (Horne et al., 1976 [PubMed 971765]). PSG is a member of the immunoglobulin (Ig) superfamily (Watanabe and Chou, 1988 [PubMed 3257488]; Streydio et al., 1988 [PubMed 3260773]).[supplied by OMIM, Oct 2009]
Canonical amino-acid sequenceUniProt
419 residues, UniProt reviewed canonical sequence.
>P11464|PSG1
1 MGTLSAPPCT QRIKWKGLLL TASLLNFWNL PTTAQVTIEA EPTKVSEGKD VLLLVHNLPQ
61 NLTGYIWYKG QMRDLYHYIT SYVVDGEIII YGPAYSGRET AYSNASLLIQ NVTREDAGSY
121 TLHIIKGDDG TRGVTGRFTF TLHLETPKPS ISSSNLNPRE TMEAVSLTCD PETPDASYLW
181 WMNGQSLPMT HSLKLSETNR TLFLLGVTKY TAGPYECEIR NPVSASRSDP VTLNLLPKLP
241 KPYITINNLN PRENKDVLNF TCEPKSENYT YIWWLNGQSL PVSPRVKRPI ENRILILPSV
301 TRNETGPYQC EIRDRYGGIR SDPVTLNVLY GPDLPRIYPS FTYYRSGEVL YLSCSADSNP
361 PAQYSWTINE KFQLPGQKLF IRHITTKHSG LYVCSVRNSA TGKESSKSMT VEVSDWTVPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 245 nTPM
Expression across tissuesHPA
Tissue
- placenta: 245 nTPM
- spleen: 0.6 nTPM
- smooth muscle: 0.5 nTPM
- stomach: 0.4 nTPM
- lung: 0.3 nTPM
- parathyroid gland: 0.2 nTPM
Single-cell type
- syncytiotrophoblasts: 286 nCPM
- retinal bipolar cells: 12 nCPM
- cone photoreceptor cells: 8.3 nCPM
- adipocytes: 6.9 nCPM
- gonadotrophs: 3 nCPM
- extravillous trophoblasts: 2.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 7.1 nTPM
- cerebral cortex: 5.6 nTPM
- amygdala: 4.8 nTPM
- thalamus: 4.4 nTPM
- hippocampal formation: 4.2 nTPM
- white matter: 4.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.99
- gnomAD pLI
- 0
- gnomAD missense Z
- -6.11
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSG1 as an antibody target. Whether an autoantibody or antibody against PSG1 could matter depends on whether native PSG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSG1 is annotated as secreted, so native PSG1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PSG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...